The following data summary aims to demonstrate and quantify patient outcomes captured using the MSK-HQ between 01/01/23 and 31/12/23. The scores were captured upon each patients initial appointment (admission) and their final appointment (discharge).This data was collected from 929 patients. The outcome measure used was the MSK-HQ. This outcome measure quantifies patients’ symptoms with a lower score indicating more severe symptoms and a higher score indicating less severe symptoms. The score ranges from 0-56. The minimal clinical important difference (MCID) for this outcome measure is 5.5.
1) The following graph demonstrates the percentage of patients that showed an improvement in their MSK HQ score and those that did not.
2) The following graph demonstrates the average admission score, average discharge score and the average change in score.
3) The following graph demonstrates the average admission and discharge scores per month for 2023.
Summary
The data above shows that the vast majority of patients that received treatment from Thorpes Physiotherapy in 2023 improved well beyond the minimal clinical important difference. In addition to this, the average patient improved by more than twice the minimally clinical important difference. This highlights that Thorpes Physiotherapy are exceeding the expectations of their NHS contract. We will continue to audit our patients annually and quarterly using the MSK-HQ.
Dominic Walcott
Clinical Lead at Thorpes Physiotherapy